Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NE-DLI in MDS and Secondary AML
NCT04620681Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Jan 2021
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
A Phase 2 trial of cd8-depleted donor lymphocyte infusion in myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), sponsored by Moffitt Cancer Center. Started Jan 2021; status: completed.
02
Drugs
cd8-depleted donor lymphocyte infusion
03
Conditions
myelodysplastic syndrome (MDS)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT04620681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04620681.